Fig. 2
From: STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylation
STMN1 expression and clinicopathological parameters and prognosis in HCC patients. The expression level of STMN1 was significantly correlated with age (A), body weight (B), AFP level (C), tumor status (D), pathological stage (E), and histological grade (F). The survival curves of OS (G), RFS (H), DSS (I), and PFS (J) of patients with high and low STMN1 expression in HCC were plotted at p < 0.05. *p < 0.05, **p < 0.01,***p < 0.001